Preview Mode Links will not work in preview mode

Jul 31, 2024

Featuring a slide presentation and related discussion from Dr Kimberly H Allison, including the following topics:

  • Pathological assessment of HER2 and appropriate testing methodologies (0:00)
  • Effect of the DESTINY-Breast04 study on clinical practice (12:32)
  • Relevancy of HER2-ultralow expression and implications of the DESTINY-Breast06 study (22:53)
  • Future directions in the pathological and clinical assessment of HER2-positive breast cancer (31:06)

CME information and select publications